The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Research works printed but not linked: 43
- Chen, 1998, Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4(+) T cells, J Exp Med, 188, 1849, 10.1084/jem.188.10.1849 · DOI · Paper page
- Hsieh, 2006, An intersection between the self-reactive regulatory and nonregulatory T-cell receptor repertoires, Nat Immunol, 7, 401, 10.1038/ni1318 · DOI · Paper page
- Tanchot, 2004, Immune regulation by self-reactive T cells is antigen specific, J Immunol, 172, 4285, 10.4049/jimmunol.172.7.4285 · DOI
- Shevach, 2002, CD4+ CD25+ suppressor T cells: more questions than answers, Nat Rev Immunol, 2, 389, 10.1038/nri821 · DOI · Paper page
- Asano, 1996, Autoimmune disease as a consequence of developmental abnormality of a T-cell subpopulation, J Exp Med, 184, 387, 10.1084/jem.184.2.387 · DOI · Paper page
- Maul, 2005, Peripheral and intestinal regulatory CD4+ CD25(high) T cells in inflammatory bowel disease, Gastroenterology, 128, 1868, 10.1053/j.gastro.2005.03.043 · DOI · Paper page
- Mottet, 2003, Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells, J Immunol, 170, 3939, 10.4049/jimmunol.170.8.3939 · DOI · Paper page
- Hori, 2002, Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T-cell receptor transgenic mice, Proc Natl Acad Sci U S A, 99, 8213, 10.1073/pnas.122224799 · DOI · Paper page
- Masteller, 2006, Antigen-specific regulatory T cells—ex vivo expansion and therapeutic potential, Semin Immunol, 18, 103, 10.1016/j.smim.2006.01.004 · DOI
- Mekala, 2005, IL-10-dependent infectious tolerance after the treatment of experimental allergic encephalomyelitis with redirected CD4+CD25+ T lymphocytes, Proc Natl Acad Sci U S A, 102, 11817, 10.1073/pnas.0505445102 · DOI
- Elinav, 2008, Redirection of regulatory T cells with predetermined specificity for the treatment of experimental colitis in mice, Gastroenterology, 134, 2014, 10.1053/j.gastro.2008.02.060 · DOI · Paper page
- Li, 2005, CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy, Blood, 106, 3068, 10.1182/blood-2005-04-1531 · DOI
- Friedmann-Morvinski, 2005, Redirected primary T cells harboring a chimeric receptor require costimulation for their antigen-specific activation, Blood, 105, 3087, 10.1182/blood-2004-09-3737 · DOI
- Eshhar, 1993, Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the γ or ξ subunits of the immunoglobulin and T-cell receptors, Proc Natl Acad Sci U S A, 90, 720, 10.1073/pnas.90.2.720 · DOI · Paper page
- Becker, 2005, In vivo imaging of colitis and colon cancer development in mice using high-resolution chromoendoscopy, Gut, 54, 950, 10.1136/gut.2004.061283 · DOI · Paper page
- Pinthus, 2004, Adoptive immunotherapy of prostate cancer bone lesions using redirected effector lymphocytes, J Clin Invest, 114, 1774, 10.1172/JCI200422284 · doi:10.1172/jci200422284
- Pandiyan, 2007, CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells, Nat Immunol, 8, 1353, 10.1038/ni1536 · DOI · Paper page
- Erhardt, 2007, IL-10, regulatory T cells, and Kupffer cells mediate tolerance in Concanavalin A-induced liver injury in mice, Hepatology, 45, 475, 10.1002/hep.21498 · DOI · Paper page
- Hombach, 2007, Effective proliferation of human regulatory T cells requires a strong costimulatory CD28 signal that cannot be substituted by IL-2, J Immunol, 179, 7924, 10.4049/jimmunol.179.11.7924 · DOI
- Kim, 2007, Generation and maturation of bone marrow-derived DCs under serum-free conditions, J Immunol Methods, 323, 101, 10.1016/j.jim.2007.03.005 · doi:10.1016/j.jim.2007.03.005
- Malek, 2008, IL-2 family of cytokines in T regulatory cell development and homeostasis, J Clin Immunol, 28, 635, 10.1007/s10875-008-9235-y · DOI
- Moriggl, 1999, Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells, Immunity, 10, 249, 10.1016/S1074-7613(00)80025-4 · DOI · Paper page
- Banz, 2002, Modulation of Fas-dependent apoptosis: a dynamic process controlling both the persistence and death of CD4 regulatory T cells and effector T cells, J Immunol, 169, 750, 10.4049/jimmunol.169.2.750 · DOI
- Weber, 2006, Adaptive islet-specific regulatory CD4 T cells control autoimmune diabetes and mediate the disappearance of pathogenic Th1 cells in vivo, J Immunol, 176, 4730, 10.4049/jimmunol.176.8.4730 · DOI
- Huang, 2004, Role of LAG-3 in regulatory T cells, Immunity, 21, 503, 10.1016/j.immuni.2004.08.010 · DOI · Paper page
- Gondek, 2005, Cutting edge: contact-mediated suppression by CD4+CD25+ regulatory cells involves a granzyme B-dependent, perforin-independent mechanism, J Immunol, 174, 1783, 10.4049/jimmunol.174.4.1783 · DOI · Paper page
- Watanabe, 2002, Administration of an antigen at a high dose generates regulatory CD4+ T cells expressing CD95 ligand and secreting IL-4 in the liver, J Immunol, 168, 2188, 10.4049/jimmunol.168.5.2188 · DOI
- Askenasy, 2005, Induction of tolerance using Fas ligand: a double-edged immunomodulator, Blood, 105, 1396, 10.1182/blood-2004-06-2364 · DOI
- Thornton, 2000, Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific, J Immunol, 164, 183, 10.4049/jimmunol.164.1.183 · DOI · Paper page
- Piccirillo, 2001, Cutting edge: control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells, J Immunol, 167, 1137, 10.4049/jimmunol.167.3.1137 · DOI · Paper page
- Sarween, 2004, CD4+CD25+ cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion, J Immunol, 173, 2942, 10.4049/jimmunol.173.5.2942 · DOI
- Kuniyasu, 2000, Naturally anergic and suppressive CD25(+)CD4(+) T cells as a functionally and phenotypically distinct immunoregulatory T-cell subpopulation, Int Immunol, 12, 1145, 10.1093/intimm/12.8.1145 · DOI · Paper page
- Duthoit, 2005, Uncoupling of IL-2 signaling from cell cycle progression in naive CD4+ T cells by regulatory CD4+CD25+ T lymphocytes, J Immunol, 174, 155, 10.4049/jimmunol.174.1.155 · DOI
- Inaba, 2006, Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T lymphocytes, Int Immunol, 18, 1043, 10.1093/intimm/dxl038 · doi:10.1093/intimm/dxl038
- Collison, 2007, The inhibitory cytokine IL-35 contributes to regulatory T-cell function, Nature, 450, 566, 10.1038/nature06306 · DOI · Paper page
- Miyara, 2007, Natural regulatory T cells: mechanisms of suppression, Trends Mol Med, 13, 108, 10.1016/j.molmed.2007.01.003 · DOI · Paper page
- Gavin, 2007, Foxp3-dependent programme of regulatory T-cell differentiation, Nature, 445, 771, 10.1038/nature05543 · DOI · Paper page
- Kim, 2007, Functional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells, Biochem Biophys Res Commun, 362, 44, 10.1016/j.bbrc.2007.07.187 · DOI
- Allan, 2008, CD4+ T-regulatory cells: toward therapy for human diseases, Immunol Rev, 223, 391, 10.1111/j.1600-065X.2008.00634.x · DOI · Paper page
- Brusko, 2008, Human regulatory T cells: role in autoimmune disease and therapeutic opportunities, Immunol Rev, 223, 371, 10.1111/j.1600-065X.2008.00637.x · DOI · Paper page
- Elpek, 2007, Ex vivo expansion of CD4+CD25+FoxP3+ T-regulatory cells based on synergy between IL-2 and 4-1BB signaling, J Immunol, 179, 7295, 10.4049/jimmunol.179.11.7295 · DOI
- Montcuquet, 2008, Regulatory T-cell expansion and function do not account for the impaired alloreactivity of ex vivo-expanded T cells, Immunology, 125, 320, 10.1111/j.1365-2567.2008.02843.x · DOI
- Kang, 2007, CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects, Am J Transplant, 7, 1457, 10.1111/j.1600-6143.2007.01829.x · DOI · Paper page
Cited by
Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor
MacDonald, K. G., Hoeppli, R. E., Huang, Q., Gillies, J., Luciani, D. S., Orban, P. C., Broady, R., & Levings, M. K. (2016) · Journal of Clinical Investigation · doi:10.1172/jci82771 · Cited by 494
Next-generation regulatory T cell therapy
Ferreira, L. M. R., Muller, Y. D., Bluestone, J. A., & Tang, Q. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0041-4 · Cited by 476
The Emerging Landscape of Immune Cell Therapies
Weber, E. W., Maus, M. V., & Mackall, C. L. (2020) · Cell · doi:10.1016/j.cell.2020.03.001 · Cited by 446
Human T Regulatory Cell Therapy: Take a Billion or So and Call Me in the Morning
Riley, J. L., June, C. H., & Blazar, B. R. (2009) · Immunity · doi:10.1016/j.immuni.2009.04.006 · Cited by 412
CAR/FoxP3-engineered T regulatory cells target the CNS and suppress EAE upon intranasal delivery
Fransson, M., Piras, E., Burman, J., Nilsson, B., Essand, M., Lu, B., Harris, R. A., Magnusson, P. U., Brittebo, E., & Loskog, A. S. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-112 · Cited by 372
Metadata
- Authors
- Elinav, E., Adam, N., Waks, T., & Eshhar, Z.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-05
- Volume
- 136
- Issue
- 5
- Pages
- 1721-1731
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2136365031
- Cited by
- 168
- References
- 3
- FWCI
- 1.78
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor. https://app.cochat.ai/papers/10.1053/j.gastro.2009.01.049
- The paper
- Elinav, E., Adam, N., Waks, T., & Eshhar, Z. (2009). Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor. Gastroenterology. https://doi.org/10.1053/j.gastro.2009.01.049
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.